Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure

Valerio De Stefano, Xingshun Qi, Jigang Wang, Xiaonan Yu, Hongyu Li, Chunyan Wu, Qingwei Zeng, Yongguo Zhang, Linan Ren, Hao Lin, Jiao Deng, Xiaozhong Guo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Hemocoagulase has been successfully used for the management of bleeding in patients undergoing surgery. Local spray of hemocoagulase during endoscopic therapy may be effective for the management of gastrointestinal bleeding. In China, intravenous infusion of hemocoagulase is given by some physicians for the treatment of gastrointestinal bleeding. However, the potential adverse events secondary to hemocoagulase, such as hypofibrinogenemia, are poorly recognized. In this paper, we reported an elderly patient with type II respiratory failure in whom hemocoagulase might induce hypofibrinogenemia and further worsen gastrointestinal bleeding. We highlighted that fibrinogen levels should be cautiously monitored in patients receiving hemocoagulase.
Original languageEnglish
Pages (from-to)71-71
Number of pages1
JournalTRANSLATIONAL GASTROINTESTINAL CANCER
Volume2017
DOIs
Publication statusPublished - 2017

Keywords

  • Endoscopy
  • Fibrinogen
  • Gastroenterology
  • Gastrointestinal bleeding
  • Hemocoagulase
  • Hepatology
  • Transfusion

Fingerprint

Dive into the research topics of 'Hemocoagulase might not control but worsen gastrointestinal bleeding in an elderly patient with type II respiratory failure'. Together they form a unique fingerprint.

Cite this